≡ Risteys
R10

Documentation Changelog GitHub Contact & Feedback

Other benign neoplasms of skin

DOID EFO MESH SNOMED Endpoint Browser PheWeb

CD2_BENIGN_SKIN

skin neoplasm: A benign or malignant tumor involving the skin. Representative examples of benign skin neoplasms include the benign melanocytic skin nevus, acanthoma, sebaceous adenoma, sweat gland adenoma, lipoma, hemangioma, fibroma, and benign fibrous histiocytoma. Representative examples of malignant skin neoplasms include basal cell carcinoma, squamous cell carcinoma, melanoma, and Kaposi sarcoma.

Endpoint definition

↥
FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D23
Cause of death: ICD-10 D23

2 out of 7 registries used, show all original rules.

12649

diagram downward connector

Check minimum number of events None

12649

diagram downward connector
diagram bullet diagram downward connector

Include endpoints

13914

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

13521

diagram downward connector
CD2_BENIGN_SKIN

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy 2
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D10-D36
Name in latin Alia neoplasmata benigna cutis

Similar endpoints

↥

List of similar endpoints to Other benign neoplasms of skin based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 13521 7978 5543
Unadjusted prevalence (%) 3.28 3.47 3.05
Mean age at first event (years) 55.08 52.55 58.74

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 1.64 [1.24, 2.16] 5.0e-4 1537
15 years 0.01 1.15 [0.94, 1.40] 1.7e-1 732
5 years 0.00 1.95 [1.66, 2.31] 1.7e-15 415
1 year 0.00 2.42 [1.90, 3.08] 5.6e-13 96

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_BENIGN_SKIN – Other benign neoplasms of skin
GWS hits: 2

Survival analyses between endpoints

↥

Plot

before Other benign neoplasms of skin
after Other benign neoplasms of skin

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Other benign neoplasms of skin

↥

Endpoint not on priority list, no data to show.